Minnesota
February 12, 2026
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment,[...]
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community